These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8399660

  • 1. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Pais MJ, Gaspar A, Santana A, Bruges M, Simões J.
    Perit Dial Int; 1993; 13 Suppl 2():S541-3. PubMed ID: 8399660
    [Abstract] [Full Text] [Related]

  • 2. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
    Abreo K, Lubom JA, Collier L, Fleming D, Work J.
    Adv Perit Dial; 1994; 10():124-8. PubMed ID: 7999809
    [Abstract] [Full Text] [Related]

  • 3. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intraperitoneal administration of recombinant human erythropoietin.
    Frenken LA, Struijk DG, Coppens PJ, Tiggeler RG, Krediet RT, Koene RA.
    Perit Dial Int; 1992 Nov; 12(4):378-83. PubMed ID: 1420497
    [Abstract] [Full Text] [Related]

  • 6. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C, Balzar E, Steger H, Lothaller MA, Frenzel K, Kohlhauser C, Kiss H, Khoss AE, Kernova T.
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [Abstract] [Full Text] [Related]

  • 7. Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients.
    Besarab A, Golper TA.
    ASAIO Trans; 1991 Nov; 37(3):M395-6. PubMed ID: 1751205
    [Abstract] [Full Text] [Related]

  • 8. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H.
    Perit Dial Int; 1992 Nov; 12(4):373-7. PubMed ID: 1420496
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of recombinant human erythropoietin administered subcutaneously to CAPD patients once weekly.
    Frifelt JJ, Tvedegaard E, Bruun K, Steffensen G, Cintin C, Breddam M, Dominguez H, Jørgensen JD.
    Perit Dial Int; 1996 Nov; 16(6):594-8. PubMed ID: 8981527
    [Abstract] [Full Text] [Related]

  • 10. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I, Goldraich N.
    Adv Perit Dial; 1992 Nov; 8():440-3. PubMed ID: 1361843
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of low-dose subcutaneous erythropoietin in hemodialysis patients.
    Parker KP, Mitch WE, Stivelman JC, Macon EJ, Bailey JL, Sands JM.
    J Am Soc Nephrol; 1997 Feb; 8(2):288-93. PubMed ID: 9048348
    [Abstract] [Full Text] [Related]

  • 12. Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease.
    Muirhead N, Churchill DN, Goldstein M, Nadler SP, Posen G, Wong C, Slaughter D, Laplante P.
    Am J Nephrol; 1992 Feb; 12(5):303-10. PubMed ID: 1488998
    [Abstract] [Full Text] [Related]

  • 13. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
    Carlini R, Obialo CI, Rothstein M.
    Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R, Bloom E, Johnson R.
    Adv Perit Dial; 1993 Feb; 9():177-80. PubMed ID: 8105918
    [Abstract] [Full Text] [Related]

  • 15. Efficient monthly subcutaneous administration of darbepoetin in stable CAPD patients.
    Theodoridis M, Passadakis P, Kriki P, Panagoutsos S, Yannatos E, Kantartzi K, Sivridis D, Vargemezis V.
    Perit Dial Int; 2005 Feb; 25(6):564-9. PubMed ID: 16411523
    [Abstract] [Full Text] [Related]

  • 16. Effects of subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Di Paolo B, Marini A, Fiederling B, Di Liberato L, Santarelli P, Bucciarelli S, Stuard S, Paolantonio L, Albertazzi A.
    Perit Dial Int; 1993 Feb; 13 Suppl 2():S538-40. PubMed ID: 8399659
    [Abstract] [Full Text] [Related]

  • 17. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo).
    Locatelli F, Canaud B, Giacardy F, Martin-Malo A, Baker N, Wilson J.
    Nephrol Dial Transplant; 2003 Feb; 18(2):362-9. PubMed ID: 12543893
    [Abstract] [Full Text] [Related]

  • 18. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y, Ito K.
    Adv Perit Dial; 1992 Feb; 8():448-52. PubMed ID: 1361845
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.
    Vanrenterghem Y, Bárány P, Mann JF, Kerr PG, Wilson J, Baker NF, Gray SJ, European/Australian NESP 970200 Study Group.
    Kidney Int; 2002 Dec; 62(6):2167-75. PubMed ID: 12427142
    [Abstract] [Full Text] [Related]

  • 20. [Anemia in peritoneal dialysis patients].
    Lausević M, Nesić V, Jovanović N, Stojimirović B.
    Srp Arh Celok Lek; 2006 Dec; 134(3-4):133-7. PubMed ID: 16915754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.